ScriptSourcing Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • ScriptSourcing's estimated annual revenue is currently $11.5M per year.(i)
  • ScriptSourcing's estimated revenue per employee is $201,000

Employee Data

  • ScriptSourcing has 57 Employees.(i)
  • ScriptSourcing grew their employee count by 30% last year.

ScriptSourcing's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Executive Assistant To CEOReveal Email/Phone
3
VP OperationsReveal Email/Phone
4
Director Data AnalyticsReveal Email/Phone
5
MAP Division ManagerReveal Email/Phone
6
National Sales ExecutiveReveal Email/Phone
7
Account Executive, Member AdvocateReveal Email/Phone
8
Financial ControllerReveal Email/Phone
9
Lead Pharmacy Operations CoordinatorReveal Email/Phone
10
Account ExecutiveReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7M35-3%N/AN/A
#2
$7.2M36-5%N/AN/A
#3
$10.5M52-9%N/AN/A
#4
$344.1M17129%N/AN/A
#5
$27.5M1376%N/AN/A
#6
$107.3M5349%N/AN/A
#7
$12.9M6428%N/AN/A
#8
$31.6M1571%N/AN/A
#9
$31.4M1567%N/AN/A
#10
$11.5M5730%N/AN/A
Add Company

What Is ScriptSourcing?

ScriptSourcing specializes in providing concierge prescription advocacy services. ScriptSourcing is able to help self-funded employers by providing $0 copay RX's to employees and dependents while substantially mitigating prescription costs. ScriptSourcing leverages decades of industry experience, highly effective risk management solutions, and proprietary technology to provide ... • $0 copay rx's • Improved medication adherence • 50-60% employer savings • Healthier, happier, and more productive employees There is no cost to implement our solutions and it is not necessary to replace your PBM.

keywords:N/A

N/A

Total Funding

57

Number of Employees

$11.5M

Revenue (est)

30%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14.7M5710%N/A
#2
$35M578%N/A
#3
N/A5730%N/A
#4
$13.9M5721%N/A
#5
$3.5M5727%N/A